| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Caribou Biosciences, Inc. (CRBU) has 0 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. CRBU is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | McClung Barbara G | Chief Legal Officer | Buy | 6,127 | $2.69 | $16,481.63 | +0.9% | -51.8% | -50.2% | |
| Oct 20, 2021 | McClung Barbara G | Chief Legal Officer | Buy | 9,219 | $2.69 | $24,799.11 | +1.4% | -45.0% | -54.6% | |
| Oct 12, 2021 | Kanner Steven | Chief Scientific Officer | Buy | 114,860 | $1.92 | $220,756.92 | +23.0% | -38.4% | -53.5% | |
| Oct 11, 2021 | Fischesser Ryan | VP Of Finance And Controller | Buy | 1,746 | $2.69 | $4,696.74 | +1.8% | -34.6% | -51.8% |